Unfortunately, many patients may choose to forego additional treatments due to the dramatic increase in cost associated with brand name versus compounded GLP-1 drugs
"We estimated that most GLP-1 [drugs] increased risk for GERD," concluded the research team led by Laurent Azoulay, an associate professor with the Jewish General Hospital's Center for Clinical Epidemiology in Montreal, Canada
Outside the submitted work, she has received grants and/or personal fees from AstraZeneca, Boehringer Ingelheim, Eli Lilly, GI Dynamics, Intarcia, Mannkind, Merck, Mylan, Novartis, Novo Nordisk, Pfizer, Sanofi, TARGET PharmaSolutions and Valeritas
Ongoing Support and Monitoring Youll have regular follow-up appointments to monitor your progress, discuss any challenges, and adjust your treatment plan as needed
Bariatric surgery as a treatment for heart failure: Review of the literature and potential mechanisms
Long-term COVID-19 symptoms in a large unselected population